General Information of Drug Therapeutic Target (DTT) (ID: TTF3I4E)

DTT Name Human papillomavirus E2 region messenger RNA (HPV E2 mRNA)
Synonyms BPV regulatory protein E2 (mRNA)
Gene Name HPV E2 mRNA
DTT Type
Literature-reported target
[1]
BioChemical Class
mRNA target
UniProt ID
VE2_BPV1
TTD ID
T85810
Sequence
METACERLHVAQETQMQLIEKSSDKLQDHILYWTAVRTENTLLYAARKKGVTVLGHCRVP
HSVVCQERAKQAIEMQLSLQELSKTEFGDEPWSLLDTSWDRYMSEPKRCFKKGARVVEVE
FDGNASNTNWYTVYSNLYMRTEDGWQLAKAGADGTGLYYCTMAGAGRIYYSRFGDEAARF
STTGHYSVRDQDRVYAGVSSTSSDFRDRPDGVWVASEGPEGDPAGKEAEPAQPVSSLLGS
PACGPIRAGLGWVRDGPRSHPYNFPAGSGGSILRSSSTPVQGTVPVDLASRQEEEEQSPD
STEEEPVTLPRRTTNDGFHLLKAGGSCFALISGTANQVKCYRFRVKKNHRHRYENCTTTW
FTVADNGAERQGQAQILITFGSPSQRQDFLKHVPLPPGMNISGFTASLDF
Function
A dimer of E2 interacts with a dimer of E1 in order to improve specificity of E1 DNA binding activity. Once the complex recognizes and binds DNA at specific sites, the E2 dimer is removed from DNA. E2 also regulates viral transcription through binding to the E2RE response element (5'-ACCNNNNNNGGT-3') present in multiple copies in the regulatory regions of the viral genome. Activates or represses transcription depending on E2RE's position with regards to proximal promoter elements including the TATA-box. Repression occurs by sterically hindering the assembly of the transcription initiation complex. Plays a role in the initiation of viral DNA replication.

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
3 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS 1751 DMBFK8A Discovery agent N.A. Investigative [2]
ISIS 1753 DMKWT6F Discovery agent N.A. Investigative [2]
ISIS 2324 DMREFCY Discovery agent N.A. Investigative [1]
------------------------------------------------------------------------------------

References

1 US patent application no. 5,457,189, Antisense oligonucleotide inhibition of papillomavirus.
2 US patent application no. 5,665,580, Antisense oligonucleotide inhibition of papillomavirus transformed cells.